Stockreport

Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF Transaction summary Metric Value Shares sold (direct) Transaction value ~$740K Post-transaction shares (direct) Post-transaction value (direct ownership) [Read more]